US Patent Issued to OSE IMMUNOTHERAPEUTICS on June 17 for "Humanized anti-human-PD-1 antibody and methods of using them for cancer treatment" (French Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,118, issued on June 17, was assigned to OSE IMMUNOTHERAPEUTICS (Nantes, France).

"Humanized anti-human-PD-1 antibody and methods of using them for cancer treatment" was invented by Nicolas Poirier (Treillieres, France), Caroline Mary (Sainte Pazanne, France), Virginie Thepenier (Sainte Pazanne, France), Aurore Morello (Saint Sebastien sur Loire, France) and Sabrina Pengam (Sainte Luce sur Loire, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are humanized anti-PD-1 antibodies, nucleic acids encoding such, and uses thereof in enhancing immune responses by activating T cells and treating diseases such as cancer and an infectiou...